Objectives: The goal of this study was to investigate the effect of pre-treatment of
mesenchymal stem cells (MSCs) with growth factors (GFs) on cardiomyogenic …

Objective: The effect of transplanted mesenchymal stem cells (MSCs) on the left ventricular
(LV) function and morphology in a rat myocardial infarct heart with reperfusion model were …

Mesenchymal stem cells (MSCs) are pluripotent cells that differentiate into a variety of cells,
including cardiomyocytes and endothelial cells. However, little information is available …

Both cell therapy and angiogenic growth factor gene therapy have been applied to animal
studies and clinical trials. Little is known about the direct comparison between cell therapy …

Transplantation of mesenchymal stem cells (MSC) improves repair and function recovery
following myocardial infarction (MI), but underlying mechanisms remain to be elucidated. We …

Growing cell-based myocardial therapies which could lead to successful myocardial repair
attracts medical interest. Even more intriguing is the observation that MSCs appears to be a …

BACKGROUND: There are several reports that engrafted mesenchymal stem cells (MSCs)
stimulate angiogenesis in the ischemic heart, but the mechanism remains controversial. We …

For decades, mesenchymal stem (MSCs) cells have been used for cardiovascular diseases
as regenerative therapy. This review is an attempt to summarize the types of MSCs involved …

Background—Mesenchymal stem cells (MSCs) offer a novel therapeutic option in the
treatment of acute myocardial infarction. MSCs are able to differentiate into myogenic cells …

Background Pretreatment of mesenchymal stem cells (MSCs) with growth factors is reported
to be an effective route for improving cell-based therapy of myocardial infarction (MI) …